Follow the people · Insider
David Young
David Young files insider transactions with the SEC as a pres. research & development of Processa Pharmaceuticals (PCSA). We hold 7 disclosed purchases and sales filed since 19 October 2006, 2 of them in the last 90 days.
- Files forPCSA
- Disclosed buys and sells7 in all, 2 in the last 90 days
- Last disclosure1 July 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 8 June 2021 — 30 June 2026Pres. Research & Development · Processa Pharmaceuticals (PCSA)60 Form 4 lines · source: SEC Form 4
- Filed 10 July 2008 — 14 August 2014Chief Scientific Officer · Questcor Pharmaceuticals (QCOR)80 Form 4 lines · source: SEC Form 4
- Filed 21 September 2006 — 30 October 2009Chief Scientific Officer · Questcor Pharmaceuticals (QSC)8 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- ▲ bought on the open market 2,531 shares of Processa PharmaceuticalsSEC Form 41 July 2026Common Stock · traded 30 June 2026 · filed 1 July 2026
- ▲ bought on the open market 2,067 shares of Processa PharmaceuticalsSEC Form 416 June 2026Common Stock · traded 15 June 2026 · filed 16 June 2026
- ▲ bought on the open market 1,786 shares of Processa PharmaceuticalsSEC Form 41 June 2026Common Stock · traded 29 May 2026 · filed 1 June 2026
- ▲ bought on the open market 1,545 shares of Processa PharmaceuticalsSEC Form 419 May 2026Common Stock · traded 15 May 2026 · filed 19 May 2026
- ▲ bought on the open market 1,706 shares of Processa PharmaceuticalsSEC Form 41 May 2026Common Stock · traded 30 April 2026 · filed 1 May 2026
- ▲ bought on the open market 1,545 shares of Processa PharmaceuticalsSEC Form 417 April 2026Common Stock · traded 15 April 2026 · filed 17 April 2026
- ▲ bought on the open market 1,810 shares of Processa PharmaceuticalsSEC Form 41 April 2026Common Stock · traded 31 March 2026 · filed 1 April 2026
- exercised options over 49 shares of Processa PharmaceuticalsSEC Form 44 February 2026Common Stock · traded 1 January 2026 · filed 4 February 2026
- exercised options over 49 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 44 February 2026Restricted Stock Units · traded 1 January 2026 · filed 4 February 2026
- exercised options over 49 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 44 February 2026Restricted Stock Units · traded 1 January 2026 · filed 4 February 2026
- exercised options over 49 shares of Processa PharmaceuticalsSEC Form 44 February 2026Common Stock · traded 1 January 2026 · filed 4 February 2026
- was granted 111,000 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 43 October 2025Restricted Stock Units · traded 1 October 2025 · filed 3 October 2025
- was granted 333,000 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 43 October 2025Stock Options (Right to Buy) · traded 1 October 2025 · filed 3 October 2025
- was granted 1,813,133 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 428 July 2025Restricted Stock Units · traded 24 July 2025 · filed 28 July 2025
- exercised options over 17,272 shares of Processa PharmaceuticalsSEC Form 411 April 2025Common Stock · traded 1 April 2025 · filed 11 April 2025
- had shares withheld for tax on 5,345 shares of Processa PharmaceuticalsSEC Form 411 April 2025Common Stock · traded 1 April 2025 · filed 11 April 2025
- was granted 124,500 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 418 February 2025Warrants · traded 29 January 2025 · filed 18 February 2025
- was granted 62,250 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 418 February 2025Warrants · traded 29 January 2025 · filed 18 February 2025
- ▲ bought on the open market 124,500 shares of Processa PharmaceuticalsSEC Form 429 January 2025Common Stock · traded 27 January 2025 · filed 29 January 2025
- was granted 3,233 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 42 August 2024Restricted Stock Units · traded 28 June 2024 · filed 2 August 2024
- was granted 2,425 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 42 August 2024Restricted Stock Units · traded 28 June 2024 · filed 2 August 2024
- was granted 404 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 42 August 2024Restricted Stock Units · traded 28 June 2024 · filed 2 August 2024
- was granted 404 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 42 August 2024Restricted Stock Units · traded 28 June 2024 · filed 2 August 2024
- exercised options over 1,675 shares of Processa PharmaceuticalsSEC Form 42 August 2024Common Stock · traded 5 April 2024 · filed 2 August 2024
- had shares withheld for tax on 518 shares of Processa PharmaceuticalsSEC Form 42 August 2024Common Stock · traded 5 April 2024 · filed 2 August 2024
- exercised options over 644 shares of Processa PharmaceuticalsSEC Form 42 August 2024Common Stock · traded 10 July 2024 · filed 2 August 2024
- had shares withheld for tax on 282 shares of Processa PharmaceuticalsSEC Form 42 August 2024Common Stock · traded 10 July 2024 · filed 2 August 2024
- exercised options over 1,675 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 412 April 2024Restricted Stock Units · traded 1 January 2024 · filed 12 April 2024
- exercised options over 1,675 shares of Processa PharmaceuticalsSEC Form 412 April 2024Common Stock · traded 1 January 2024 · filed 12 April 2024
- had shares withheld for tax on 518 shares of Processa PharmaceuticalsSEC Form 412 April 2024Common Stock · traded 1 January 2024 · filed 12 April 2024
- ▲ bought on the open market 21,000 shares of Processa PharmaceuticalsSEC Form 48 February 2024Common Stock · traded 7 February 2024 · filed 8 February 2024
- ▲ bought on the open market 20,000 shares of Processa PharmaceuticalsSEC Form 47 February 2024Common Stock · traded 6 February 2024 · filed 7 February 2024
- was granted 155,277 shares of Processa PharmaceuticalsSEC Form 412 October 2023Common Stock · traded 12 October 2023 · filed 12 October 2023
- was granted 142,000 shares of Processa PharmaceuticalsSEC Form 410 October 2023Common Stock · traded 10 October 2023 · filed 10 October 2023
- ▲ bought on the open market 40,000 shares of Processa PharmaceuticalsSEC Form 412 June 2023Common Stock · traded 12 June 2023 · filed 12 June 2023
- ▲ bought on the open market 20,000 shares of Processa PharmaceuticalsSEC Form 414 April 2023Common Stock · traded 14 April 2023 · filed 14 April 2023
- ▲ bought on the open market 20,000 shares of Processa PharmaceuticalsSEC Form 413 April 2023Common Stock · traded 11 April 2023 · filed 13 April 2023
- ▲ bought on the open market 20,000 shares of Processa PharmaceuticalsSEC Form 413 April 2023Common Stock · traded 12 April 2023 · filed 13 April 2023
- ▲ bought on the open market 20,000 shares of Processa PharmaceuticalsSEC Form 413 April 2023Common Stock · traded 13 April 2023 · filed 13 April 2023
- was granted 18,750 shares of Processa PharmaceuticalsSEC Form 410 February 2023Common Stock · traded 9 February 2023 · filed 10 February 2023
- was granted 25,350 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 44 January 2023Restricted Stock Units · traded 31 December 2022 · filed 4 January 2023
- was granted 24,030 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 44 January 2023Restricted Stock Units · traded 1 January 2023 · filed 4 January 2023
- was granted 25,350 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 43 October 2022Restricted Stock Units · traded 30 September 2022 · filed 3 October 2022
- gave away 9,250 shares of Processa PharmaceuticalsSEC Form 423 August 2022Common Stock · traded 16 August 2022 · filed 23 August 2022
- exercised options over 7,601 shares of Processa PharmaceuticalsSEC Form 49 August 2022Common Stock · traded 5 August 2022 · filed 9 August 2022
- had shares withheld for tax on 2,531 shares of Processa PharmaceuticalsSEC Form 49 August 2022Common Stock · traded 5 August 2022 · filed 9 August 2022
- was granted 46,877 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 45 July 2022Restricted Stock Units · traded 30 June 2022 · filed 5 July 2022
- was granted 247,841 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 411 April 2022Restricted Stock Units · traded 1 April 2022 · filed 11 April 2022
- was granted 4,286 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 44 April 2022Restricted Stock Units · traded 1 November 2021 · filed 4 April 2022
- was granted 10,715 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 44 April 2022Restricted Stock Units · traded 31 March 2022 · filed 4 April 2022
- was granted 6,024 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 46 January 2022Restricted Stock Units · traded 30 September 2021 · filed 6 January 2022
- was granted 6,722 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 46 January 2022Restricted Stock Units · traded 31 December 2021 · filed 6 January 2022
- was granted 6,722 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 44 January 2022Restricted Stock Units · traded 31 December 2021 · filed 4 January 2022
- was granted 6,024 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 44 October 2021Restricted Stock Units · traded 30 September 2021 · filed 4 October 2021
- was granted 7,601 shares of Processa PharmaceuticalsSEC Form 49 August 2021Common Stock · traded 5 August 2021 · filed 9 August 2021
- was granted 8,572 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 49 July 2021Restricted Stock Units · traded 8 July 2021 · filed 9 July 2021
- was granted 12,858 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 49 July 2021Restricted Stock Units · traded 8 July 2021 · filed 9 July 2021
- was granted 1,907 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 49 July 2021Restricted Stock Units · traded 8 July 2021 · filed 9 July 2021
- ▲ bought on the open market 10,000 shares of Processa PharmaceuticalsSEC Form 423 June 2021Common Stock · traded 23 June 2021 · filed 23 June 2021
- was granted 8,127 shares of Processa Pharmaceuticals (a derivative holding)SEC Form 410 June 2021Restricted Stock Units · traded 8 June 2021 · filed 10 June 2021
- returned to the issuer 70,991 shares of Questcor PharmaceuticalsSEC Form 418 August 2014Common Stock · traded 14 August 2014 · filed 18 August 2014
- returned to the issuer 32,750 shares of Questcor PharmaceuticalsSEC Form 418 August 2014Common Stock · traded 14 August 2014 · filed 18 August 2014
- returned to the issuer 14,000 shares of Questcor PharmaceuticalsSEC Form 418 August 2014Common Stock · traded 14 August 2014 · filed 18 August 2014
- returned to the issuer 1,500 shares of Questcor Pharmaceuticals (a derivative holding)SEC Form 418 August 2014Stock Option (right to buy) · traded 14 August 2014 · filed 18 August 2014
- returned to the issuer 22,500 shares of Questcor Pharmaceuticals (a derivative holding)SEC Form 418 August 2014Stock Option (right to buy) · traded 14 August 2014 · filed 18 August 2014
- returned to the issuer 71,000 shares of Questcor Pharmaceuticals (a derivative holding)SEC Form 418 August 2014Stock Option (right to buy) · traded 14 August 2014 · filed 18 August 2014
- returned to the issuer 85,416 shares of Questcor Pharmaceuticals (a derivative holding)SEC Form 418 August 2014Stock Option (right to buy) · traded 14 August 2014 · filed 18 August 2014
- returned to the issuer 74,375 shares of Questcor Pharmaceuticals (a derivative holding)SEC Form 418 August 2014Stock Option (right to buy) · traded 14 August 2014 · filed 18 August 2014
- exercised options over 6,000 shares of Questcor PharmaceuticalsSEC Form 426 June 2014Common Stock · traded 24 June 2014 · filed 26 June 2014
- ▼ sold on the open market 6,000 shares of Questcor PharmaceuticalsSEC Form 426 June 2014Common Stock · traded 24 June 2014 · filed 26 June 2014
- exercised options over 6,000 shares of Questcor Pharmaceuticals (a derivative holding)SEC Form 426 June 2014Stock Option (right to buy) · traded 24 June 2014 · filed 26 June 2014
- exercised options over 6,000 shares of Questcor PharmaceuticalsSEC Form 418 March 2014Common Stock · traded 14 March 2014 · filed 18 March 2014
- ▼ sold on the open market 2,587 shares of Questcor PharmaceuticalsSEC Form 418 March 2014Common Stock · traded 14 March 2014 · filed 18 March 2014
- ▼ sold on the open market 3,413 shares of Questcor PharmaceuticalsSEC Form 418 March 2014Common Stock · traded 14 March 2014 · filed 18 March 2014
- exercised options over 6,000 shares of Questcor Pharmaceuticals (a derivative holding)SEC Form 418 March 2014Stock Option (right to buy) · traded 14 March 2014 · filed 18 March 2014
- exercised options over 6,000 shares of Questcor PharmaceuticalsSEC Form 45 March 2014Common Stock · traded 3 March 2014 · filed 5 March 2014
- exercised options over 6,000 shares of Questcor Pharmaceuticals (a derivative holding)SEC Form 45 March 2014Stock Option (right to buy) · traded 3 March 2014 · filed 5 March 2014
- was granted 14,000 shares of Questcor PharmaceuticalsSEC Form 426 February 2014Common Stock · traded 24 February 2014 · filed 26 February 2014
- was granted 14,000 shares of Questcor PharmaceuticalsSEC Form 426 February 2014Common Stock · traded 24 February 2014 · filed 26 February 2014
- returned to the issuer 16,667 shares of Questcor PharmaceuticalsSEC Form 426 February 2014Common Stock · traded 24 February 2014 · filed 26 February 2014
- had shares withheld for tax on 17,127 shares of Questcor PharmaceuticalsSEC Form 426 February 2014Common Stock · traded 24 February 2014 · filed 26 February 2014
- exercised options over 6,000 shares of Questcor PharmaceuticalsSEC Form 426 February 2014Common Stock · traded 24 February 2014 · filed 26 February 2014
- ▼ sold on the open market 6,000 shares of Questcor PharmaceuticalsSEC Form 426 February 2014Common Stock · traded 24 February 2014 · filed 26 February 2014
- exercised options over 6,000 shares of Questcor Pharmaceuticals (a derivative holding)SEC Form 426 February 2014Stock Option (right to buy) · traded 24 February 2014 · filed 26 February 2014
- exercised options over 10,000 shares of Questcor PharmaceuticalsSEC Form 431 January 2014Common Stock · traded 29 January 2014 · filed 31 January 2014
- exercised options over 10,000 shares of Questcor PharmaceuticalsSEC Form 431 January 2014Common Stock · traded 29 January 2014 · filed 31 January 2014
- exercised options over 10,000 shares of Questcor Pharmaceuticals (a derivative holding)SEC Form 431 January 2014Stock Option (right to buy) · traded 29 January 2014 · filed 31 January 2014
- exercised options over 10,000 shares of Questcor Pharmaceuticals (a derivative holding)SEC Form 431 January 2014Stock Option (right to buy) · traded 29 January 2014 · filed 31 January 2014
- exercised options over 6,000 shares of Questcor PharmaceuticalsSEC Form 428 January 2014Common Stock · traded 24 January 2014 · filed 28 January 2014
- ▼ sold on the open market 6,000 shares of Questcor PharmaceuticalsSEC Form 428 January 2014Common Stock · traded 24 January 2014 · filed 28 January 2014
- exercised options over 6,000 shares of Questcor Pharmaceuticals (a derivative holding)SEC Form 428 January 2014Stock Option (right to buy) · traded 24 January 2014 · filed 28 January 2014
- exercised options over 15,000 shares of Questcor Pharmaceuticals (a derivative holding)SEC Form 421 November 2013Stock Option (right to buy) · traded 19 November 2013 · filed 21 November 2013
- exercised options over 15,000 shares of Questcor PharmaceuticalsSEC Form 421 November 2013Common Stock · traded 19 November 2013 · filed 21 November 2013
- exercised options over 100,000 shares of Questcor Pharmaceuticals (a derivative holding)SEC Form 415 November 2013Stock Option (right to buy) · traded 13 November 2013 · filed 15 November 2013
- exercised options over 100,000 shares of Questcor PharmaceuticalsSEC Form 415 November 2013Common Stock · traded 13 November 2013 · filed 15 November 2013
- ▼ sold on the open market 100,000 shares of Questcor PharmaceuticalsSEC Form 415 November 2013Common Stock · traded 13 November 2013 · filed 15 November 2013
- was granted 21,325 shares of Questcor PharmaceuticalsSEC Form 412 April 2013Common Stock · traded 24 February 2013 · filed 12 April 2013
- was granted 25,000 shares of Questcor PharmaceuticalsSEC Form 412 April 2013Common Stock · traded 24 February 2013 · filed 12 April 2013
- was granted 25,000 shares of Questcor PharmaceuticalsSEC Form 412 April 2013Common Stock · traded 24 February 2013 · filed 12 April 2013
- gave away 10,625 shares of Questcor PharmaceuticalsSEC Form 48 March 2013Common Stock · traded 7 March 2013 · filed 8 March 2013
- gave away 10,625 shares of Questcor PharmaceuticalsSEC Form 48 March 2013Common Stock · traded 7 March 2013 · filed 8 March 2013
- was granted 21,332 shares of Questcor PharmaceuticalsSEC Form 426 February 2013Common Stock · traded 24 February 2013 · filed 26 February 2013
- was granted 25,000 shares of Questcor PharmaceuticalsSEC Form 426 February 2013Common Stock · traded 24 February 2013 · filed 26 February 2013
- was granted 25,000 shares of Questcor PharmaceuticalsSEC Form 426 February 2013Common Stock · traded 24 February 2013 · filed 26 February 2013
- exercised options over 625 shares of Questcor Pharmaceuticals (a derivative holding)SEC Form 414 August 2012Stock Option (right to purchase) · traded 10 August 2012 · filed 14 August 2012
- exercised options over 10,000 shares of Questcor Pharmaceuticals (a derivative holding)SEC Form 414 August 2012Stock Option (right to purchase) · traded 10 August 2012 · filed 14 August 2012
- exercised options over 625 shares of Questcor PharmaceuticalsSEC Form 414 August 2012Common Stock · traded 10 August 2012 · filed 14 August 2012
- exercised options over 10,000 shares of Questcor PharmaceuticalsSEC Form 414 August 2012Common Stock · traded 10 August 2012 · filed 14 August 2012
- exercised options over 70,000 shares of Questcor Pharmaceuticals (a derivative holding)SEC Form 41 May 2012Stock Option (right to buy) · traded 27 April 2012 · filed 1 May 2012
- exercised options over 70,000 shares of Questcor PharmaceuticalsSEC Form 41 May 2012Common Stock · traded 27 April 2012 · filed 1 May 2012
- ▼ sold on the open market 70,000 shares of Questcor PharmaceuticalsSEC Form 41 May 2012Common Stock · traded 27 April 2012 · filed 1 May 2012
- was granted 90,000 shares of Questcor Pharmaceuticals (a derivative holding)SEC Form 417 February 2012Stock Option (Right to Buy) · traded 15 February 2012 · filed 17 February 2012
- was granted 20,000 shares of Questcor Pharmaceuticals (a derivative holding)SEC Form 417 February 2012Stock Option (Right to Buy) · traded 15 February 2012 · filed 17 February 2012
- exercised options over 75,000 shares of Questcor Pharmaceuticals (a derivative holding)SEC Form 42 November 2011Stock Option (Right to Buy) · traded 31 October 2011 · filed 2 November 2011
- exercised options over 75,000 shares of Questcor PharmaceuticalsSEC Form 42 November 2011Common Stock · traded 31 October 2011 · filed 2 November 2011
- ▼ sold on the open market 75,000 shares of Questcor PharmaceuticalsSEC Form 42 November 2011Common Stock · traded 31 October 2011 · filed 2 November 2011
- ▼ sold on the open market 4,724 shares of Questcor PharmaceuticalsSEC Form 42 November 2011Common Stock · traded 31 October 2011 · filed 2 November 2011
- exercised options over 9,208 shares of Questcor Pharmaceuticals (a derivative holding)SEC Form 416 August 2011Stock Option (Right to Buy) · traded 12 August 2011 · filed 16 August 2011
- exercised options over 5,792 shares of Questcor Pharmaceuticals (a derivative holding)SEC Form 416 August 2011Stock Option (Right to Buy) · traded 15 August 2011 · filed 16 August 2011
- exercised options over 9,208 shares of Questcor PharmaceuticalsSEC Form 416 August 2011Common Stock · traded 12 August 2011 · filed 16 August 2011
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.